about
Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studiesCentral muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitisThe relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewA novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 inductionThe complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice.Heat shock factor 2 levels are associated with the severity of ulcerative colitisRole of genetics in the diagnosis and prognosis of Crohn's diseaseProtective Effect of Calculus Bovis Sativus on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice.Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials.NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signalingNutrition of the critically ill — a 21st-century perspective.Protective Effect of Amphipterygium adstringens Extract on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice.Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis.Increased preventive effect on colon carcinogenesis by use of resistant starch (RS3) as the carrier for polysaccharide of Larimichthys crocea swimming bladder.Nutrition of the critically ill - emphasis on liver and pancreasAdministration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation.Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation.Changes of the cytokine profile in inflammatory bowel diseases.Hydroxylases as therapeutic targets in inflammatory bowel disease.Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.Pu-erh tea has in vitro anticancer activity in TCA8113 cells and preventive effects on buccal mucosa cancer in U14 cells injected mice in vivo.Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis.Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells.Comparative Evaluation between Sulfasalazine Alone and in Combination with Herbal Medicine on DSS-Induced Ulcerative Colitis Mice.Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways.Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice.
P2860
Q26991673-0D71B3EF-E29B-468F-B82F-D57E762FBBB7Q27340307-4C83E6B1-B204-49BC-A9D6-084BC655FF4BQ28078219-A1888EDD-E4F1-4A0A-BD4A-E50CFE536BB1Q34011478-991845E3-2E29-459C-8B29-E9E799415328Q34701117-D3D9FC4F-6ECC-4280-B31B-A2E219131344Q35095575-CFFA2EFA-8CF9-4D88-BFFD-3C2E5D46B79BQ35638770-1C9BED07-C43C-4002-9356-B546D1F113A5Q36249551-D93E5C6A-AB2A-46AB-BECE-60B242F71E17Q36321264-B43BC076-68B9-47B9-9B6B-8D055AE9F58CQ36341390-323C540B-406F-470C-8084-21BFA53E8475Q36438334-102471FD-D21C-405F-8725-CAE29A48E2BFQ36607663-9143E795-C401-45E7-9586-CABBB65098EAQ37231740-75D7AB55-F5E1-4905-9581-7EEEB1DDC156Q37384908-6EF9E75D-6736-4A5C-B016-D8A59B0C14B7Q37535542-1CF4E7F6-A3E9-47EC-BE89-F223DEB6EFFEQ37584566-B65EB422-1ABD-46F7-B592-77873EAF9E50Q37591672-4FD2A742-44FE-4FB4-B86B-274322A95F80Q37686354-6166E498-45F5-4D8C-9EB2-0C0EB65152C6Q38058782-40DAF414-0305-48A8-AEDD-FC916E8C2FE6Q38082620-2F30E7B5-C79F-4746-AA33-F8F340A97D90Q38177338-C4558778-E9F9-4F95-9202-913353B8F31DQ38683067-7E50A201-681E-4225-9874-2FA67590474FQ38982962-F879FC52-80AD-4286-B19C-9E21EBC32D02Q40804998-0A450C19-7066-4222-9A19-F1BE2CE1691AQ41884115-4FA91B9E-49C1-4547-9BF2-98FD0F851B52Q42176677-7881F734-B378-4A69-8066-BBDCB802DB5EQ42177619-C84DBCD4-1EF9-4DC2-8B5C-EC0E2D255DEBQ42468336-EE05DF93-66B6-4F02-AE96-7FC1DEC77C7EQ48172718-69F0C378-5595-47D2-9B70-180676CFAF46Q52689572-594CB043-55F0-4B63-8A37-164B4B5E8899Q55344717-2F6D60DF-0DE7-402B-8528-E04ABE9912F8
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Cytokine blockade in inflammatory bowel diseases.
@en
Cytokine blockade in inflammatory bowel diseases.
@nl
type
label
Cytokine blockade in inflammatory bowel diseases.
@en
Cytokine blockade in inflammatory bowel diseases.
@nl
prefLabel
Cytokine blockade in inflammatory bowel diseases.
@en
Cytokine blockade in inflammatory bowel diseases.
@nl
P2860
P356
P1433
P1476
Cytokine blockade in inflammatory bowel diseases.
@en
P2093
Clémentine Perrier
P2860
P304
P356
10.2217/IMT.11.122
P577
2011-11-01T00:00:00Z